Study results for enzalutamide in prostate cancer publishedAstellas Pharma Inc
CORRECTEDSeptember 15, 2016 // In a landmark study, prostate-cancer survival was not significantly different among men with localized disease in the 3 different treatment groups (prostatectomy, radiation, and monitoring), according to 10-year resultspublished todayin theNew England Journal of Medicine...
Deguelin, an inhibitor of mitochondira in cells, can be used to target lethal prostate cancers lacking the gene PTEN. Left: cancerous mouse prostate cells glow green. Right: After 10 weeks of treatment with deguelin, only a few cancer cells remain. This compound and another called rotenone, ...
The few previous studies examining the association between asthma or allergy and prostate cancer (PCa) risk were inconclusive. This study aimed to evaluate these associations, and to explore in details the possible influence of current versus former allergic condition, age at onset, time since onset...
Prostate cancer cases are set to double by 2040, according to researchers who have called on authorities to "take action now" as the rise is "inevitable". The study by the Lancet Commission on prostatecancersuggests that deaths are expected to double from 1.4...
Urology 66 (Suppl 5A): S47–S51 Experience counts: MRI-based prostate-cancer staging Controversy rages over which imaging tech- nique to use in the localization and staging of prostate cancer. Many small studies have been done, with contradictory results, but the differences in the imaging ...
Prostate cancer, disease characterized by uncontrolled growth of cells within the prostate gland. Prostate cancer is a frequently diagnosed cancer among males. Learn more about the causes, symptoms, and treatment of prostate cancer.
Findings from the first international prostate cancer quality of life study conducted by patients themselves reports that significant numbers of men treated for the disease are struggling with continence and sexual problems after treatment. Results suggest that any treatment apart from active surveillance ...
Impact of aspirin on biochemical recurrence of prostate cancer after robot assisted radical prostatectomy in a multicenter retrospective cohort study Shuhei Suzuki Hiromitsu Negoro Takashi Kobayashi ResearchOpen Access15 Jan 2025 Scientific Reports Volume: 15, P: 2025 The burden of prostate cancer in...
“There’s been no hard evidence that treating early disease makes a difference,” said Dr. Freddie Hamdy of the University of Oxford, the study’s leader. “Because we cannot determine very well which isaggressive cancerand which is not, men and clinicians can both be anxious about wh...